Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Monthly Archives: May 2015

Bill Expanding Prescription Monitoring Program Sent to Governor Christie

Trenton, NJ, May 21, 2015 ― Legislation sponsored by Senate Majority Leader Loretta Weinberg and Senate Health Chairman Joseph F. Vitale to update, expand and improve the state’s Prescription Monitoring Program (PMP) to protect against patient abuse of addictive prescription medications was approved on May 18 by the Senate, sending the bill to Governor Chris Christie’s desk.

The Senate approved the bill by a vote of 34-0.  The Assembly approved it 74-0.  The law would take effect on the first day of the fourth month following the date of enactment. Continue reading

Study: Personalized Medicine Is Gaining Traction, But Faces Multiple Challenges

Boston, MA, May 21, 2015 ― While development of personalized medicines has grown since the human genome was first sequenced in 2001, biopharmaceutical sponsors face a number of hurdles that are impeding more rapid market uptake, according to a recently completed study by the Tufts Center for the Study of Drug Development.

Fourteen years after the human genome was initially sequenced, paving the way for development of personalized medicine, 13 percent of drugs marketed in the United States today post pharmacogenomic information on the label, Tufts CSDD reported.

However, developers continue to encounter challenges relating to basic science, regulatory and reimbursement policies, and, equally critical, clinical adoption, Tufts CSDD added. Continue reading

U.S. House Energy and Commerce Committee Unanimously Passes ‘21st Century Cures Act’

 Washington, DC, May 21, 2015 ― The House Energy and Commerce Committee this morning unanimously approved the nonpartisan 21st Century Cures Act 51-0.

The nonpartisan legislation will help to modernize and personalize health care, encourage greater innovation, support research, and streamline the system to deliver better, faster cures to more patients.

The bill has seen continued support throughout the process.  H.R. 6, the 21st Century Cures Act, was authored by full committee Chairman Fred Upton (R-MI), Oversight and Investigations Subcommittee Ranking Member DeGette, full committee Ranking Member Frank Pallone, Jr. (D-NJ), Health Subcommittee Chairman Joe Pitts (R-PA), and Health Subcommittee Ranking Member Gene Green (D-TX). Continue reading

Health Commissioner O’Dowd and Children and Families Commissioner Blake Offer Tips Safe Summer Tips

Trenton, NJ, May 21, 2015 ― Health Commissioner Mary O’Dowd and Children and Families Commissioner Allison Blake Offer Tips for a Safe Summer Season

As the unofficial start of summer approaches, the New Jersey Departments of Health (DOH) and Children and Families (DCF) are reminding residents and their families to take precautions to be safe in the water and protect against the sun’s ultraviolet rays-especially in infants and children. Continue reading

Event: ‘Century for the Cure’ Bike Ride on Sept. 20 Will Add to $1.4M Raised for Rutgers Cancer Institute NJ

New Brunswick, NJ, May 20, 2015 ― Having contributed $1.4 million over the past decade to research efforts at Rutgers Cancer Institute of New Jersey, the Century for the Cure charity bike ride is gearing up for another successful year.  Registration is now open for this year’s September 20 event, and organizers are hoping to raise $300,000.

“We ride for family. We ride for friends. We ride because we can,” notes ride founder Scott Glickman.

A cycling enthusiast, Glickman rode in a high-profile event in Massachusetts for years until he was sidelined briefly from this passion.  It was in the late 1990s when he was diagnosed with stage IV non-Hodgkin’s lymphoma and wasn’t sure if he would ever ride again. Continue reading

In Wall Street Journal Op-Ed, Gov. Christie Says Innovation Should Be an Economic Priority

Trenton, NJ, May 19, 2015 ― In his recent opinion piece published in The Wall Street Journal, Governor Chris Christie outlined a five-point economic plan for the United States.  One of those points was a commitment to innovation.

In his opinion piece entitled “My Plan to Raise Growth and Incomes,” Governor Christie said the fundamental question facing the country right now was: Why has the income of middle-class Americans failed to grow for 15 years?

“Until we answer this question and fix this problem, the anxiety and unhappiness that weighs on middle-class America will not be resolved,” Christie wrote.  “We will continue to see mistrust between the people and their government. We will continue to see America weakened in the world.” Continue reading

Christie Administration Recognizes and Thanks New Jersey’s Emergency Medical Services Professionals

Trenton, NJ, May 18, 2015 ― Marking National Emergency Medical Services (EMS) Week (May 17-23), New Jersey Health Commissioner Mary O’Dowd thanked the nearly 30,000 EMS professionals throughout New Jersey for their commitment and dedication to service.

“New Jersey’s EMS professionals put their lives on the line every day to respond to more than one million calls and are available 24 hours a day,” said Commissioner O’Dowd.   Continue reading

Bill to Ensure Safe Disposal of Prescription Drugs Gains Final Legislative Approval

Trenton, NJ, May 17, 2015 ― Legislation sponsored by Assembly Democrats Dan Benson, Shavonda Sumter and Joseph Lagana to help curb New Jersey’s heroin and opioid crisis gained final legislative approval on Thursday in the Assembly.

The bill (A709) would require pharmacies and prescribers to supply patients with a Division of Consumer Affairs notice publicizing available drug take-back programs and giving suggestions for the safe disposal of drugs with each controlled dangerous substance dispensed. Continue reading

NJ Assembly Approves Bill to Make Cost-Effective Biological Drug Alternatives More Widely Available

Trenton, NJ, May 15, 2015 ― The full Assembly on Thursday unanimously approved legislation sponsored by Assembly Democrats Pamela Lampitt, Herb Conaway, Jr., M.D., Daniel Benson, Shavonda Sumter, Angel Fuentes and Nancy Pinkin to make it easier for consumers to obtain more cost-effective, “generic” versions of biological medicines used to treat conditions such as rheumatoid arthritis, anemia, psoriasis and various forms of cancer.

“The FDA has created a safe pathway to make alternative biological medicines more readily available on the market,” said Lampitt (D-Camden / Burlington).  “If there is a more cost-effective option to treat and cure various illnesses, then by all means we should be helping patients pursue it.” Continue reading

U.S. Introduces New DNA Standard for Ensuring Accuracy of Genetic Tests

Washington, DC, May 15, 2015 ― Robert Pear reports in The New York Times that the federal government has opened the door to a new era of genetic medicine by introducing a standard way to ensure the accuracy of DNA tests used to tailor treatments for individual patients.

Scientists have identified hundreds of genetic mutations that appear to increase the risk of diseases, including cancer, Alzheimer’s and cystic fibrosis. But laboratories often report different results when they analyze genes obtained from samples of the same blood or tissue, because of variations in their testing equipment and methods. Continue reading